Intervention Review

Postoperative tamoxifen for ductal carcinoma in situ

  1. Helen Staley1,
  2. Iain McCallum1,*,
  3. Julie Bruce2

Editorial Group: Cochrane Breast Cancer Group

Published Online: 17 OCT 2012

Assessed as up-to-date: 16 AUG 2011

DOI: 10.1002/14651858.CD007847.pub2

How to Cite

Staley H, McCallum I, Bruce J. Postoperative tamoxifen for ductal carcinoma in situ. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD007847. DOI: 10.1002/14651858.CD007847.pub2.

Author Information

  1. 1

    North Tyneside General Hospital, Northumbria Healthcare NHS Foundation Trust, North Shields, Tyne & Wear, UK

  2. 2

    University of Warwick, Warwick Clinical Trials Unit, Coventry, UK

*Iain McCallum, Northumbria Healthcare NHS Foundation Trust, North Tyneside General Hospital, Rake Lane, North Shields, Tyne & Wear, NE29 8NH, UK. iainmccallum@nhs.net.

Publication History

  1. Publication Status: New
  2. Published Online: 17 OCT 2012

SEARCH

  1. Current Version

    Postoperative tamoxifen for ductal carcinoma in situ

    Helen Staley, Iain McCallum and Julie Bruce

    Article first published online: 17 OCT 2012 | DOI: 10.1002/14651858.CD007847.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Postoperative tamoxifen for ductal carcinoma in situ

    Iain McCallum, Wendy Craig and Julie Bruce

    Article first published online: 15 APR 2009 | DOI: 10.1002/14651858.CD007847